Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Human adipose stromal/stem cells from obese donors show reduced efficacy in halting disease progression in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
Factors Associated with Employment Status in Individuals with Multiple Sclerosis.
Multiple sclerosis: Evidence for B-cell exchange across the blood-brain barrier.
Adult-onset Krabbe disease presenting with an isolated form of peripheral neuropathy.
Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis.
Prophylactic antiepileptic treatment reduces seizure frequency in natalizumab-associated progressive multifocal leukoencephalopathy.
An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders.
Cognitive Impairment and Its Relation to Imaging Measures in Multiple Sclerosis: A Study Using a Computerized Battery.
Interferon-Beta: Neutralizing Antibodies, Binding Antibodies, Pharmacokinetics and Pharmacodynamics, and Clinical Outcomes.
Disease mechanisms in MS: Neuronal network connectivity is altered in multiple sclerosis.
White and gray matter damage in primary progressive MS: The chicken or the egg?
Validity and reliability of the FSS in Greek MS patients.
Job placement interventions for people with multiple sclerosis.
Validity of Minimal Clinically Important Difference Values for the Multiple Sclerosis Walking Scale-12?
Ubiquitous Over-Expression of Chromatin Remodeling Factor SRG3 Ameliorates the T Cell-Mediated Exacerbation of EAE by Modulating the Phenotypes of both Dendritic Cells and Macrophages.
Disease Activity Free Status: A New End Point for a New Era in Multiple Sclerosis Clinical Research?
Glial cell biology in the Great Lakes region.
Interleukin-12p40 in the spinal fluid as a biomarker for clinically isolated syndrome.
Single Dose of Glycoengineered Anti-CD19 Antibody (MEDI551) Disrupts Experimental Autoimmune Encephalomyelitis by Inhibiting Pathogenic Adaptive Immune Responses in the Bone Marrow and Spinal Cord While Preserving Peripheral Regulatory Mechanisms.
External memory aids for memory problems in people with multiple sclerosis: A systematic review.
Vitamin D and the central nervous system.
Takayasu arteritis associated with ulcerative colitis and optic neuritis: first case in Korea.
Primary progressive multiple sclerosis: progress and challenges.
Quantifying gait impairment using an instrumented treadmill in people with multiple sclerosis.
Sporadic Porphyria Cutanea Tarda in a Patient with Multiple Sclerosis Treated with Interferon Beta 1-a Therapy: A Case Report.
Pages
« first
‹ previous
…
459
460
461
462
463
464
465
466
467
…
next ›
last »